[ O- methyl-11C] N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1 H-indole-2-carboxamide ([11C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D₃ Receptors in Rodents and Monkey

Molecules. 2018 Oct 23;23(11):2737. doi: 10.3390/molecules23112737.

Abstract

Selective high-affinity antagonists for the dopamine D₃ receptor (D₃R) are sought for treating substance use disorders. Positron emission tomography (PET) with an effective D₃R radioligand could be a useful tool for the development of such therapeutics by elucidating pharmacological specificity and target engagement in vivo. Currently, a D₃R-selective radioligand does not exist. The D₃R ligand, N-(4-(4-(3-chloro-2-methoxyphenyl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide (BAK4-51, 1), has attractive properties for PET radioligand development, including full antagonist activity, very high D₃R affinity, D₃R selectivity, and moderate lipophilicity. We labeled 1 with the positron-emitter carbon-11 (t1/2 = 20.4 min) in the methoxy group for evaluation as a radioligand in animals with PET. However, [11C]1 was found to be an avid substrate for brain efflux transporters and lacked D₃R-specific signal in rodent and monkey brain in vivo.

Keywords: PET; antagonist; dopamine D3 receptors; efflux transporter substrate; radiolabeling.

MeSH terms

  • Animals
  • Brain / diagnostic imaging*
  • Brain / metabolism*
  • Dopamine Agents / chemistry
  • Dopamine Agents / metabolism*
  • Haplorhini
  • Mice
  • Molecular Structure
  • Neuroimaging* / methods
  • Positron-Emission Tomography* / methods
  • Radiopharmaceuticals / chemistry
  • Radiopharmaceuticals / metabolism*
  • Rats
  • Receptors, Dopamine D3 / metabolism*
  • Rodentia

Substances

  • Dopamine Agents
  • Radiopharmaceuticals
  • Receptors, Dopamine D3